Nachrichten Nachrichten Nachrichten

Nachrichten

Portfolio

Biotalys submits first protein-based biocontrol registration package to the EPA

21/01/2021 - 10:00

Portfolio

Gimv sells OTN Systems, a provider of telecommunication solutions for industrial markets, to listed Belden Inc.

19/01/2021 - 14:30

Portfolio

Cegeka and Citymesh join forces to form a fourth national operator in Belgium

10/12/2020 - 11:00

Portfolio

Gimv sells Itho Daalderop-Climate for Life - Dutch market leader in integrated sustainable solutions for energy-neutral living in the Benelux - to Parcom

02/12/2020 - 07:30

Portfolio

Gimv is founding investor of Kinaset Therapeutics in a USD 40m Series A round – funds used to develop novel therapeutics for respiratory diseases

30/11/2020 - 08:00

Portfolio

Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market

25/11/2020 - 09:00

Portfolio

Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors

19/11/2020 - 07:30

Corporate

Beteiligungsgesellschaft Gimv: Starke Ergebnisse dank eines widerstandsfähigen Portfolios

19/11/2020 - 07:00

Portfolio

ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01

11/11/2020 - 13:00

Portfolio

Die Firmengruppe Köberl beginnt Wachstumsinitiative mit dem Erwerb der 089 Immobilienmanagement GmbH

06/11/2020 - 08:10

Portfolio

Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq

22/10/2020 - 17:55

Portfolio

Topas Therapeutics raises EUR 22 Million in Series B Financing and appoints new CEO

19/10/2020 - 09:18

Kontaktinformation

Pressekontact

Haben Sie noch Fragen oder benötigen Sie weitere Informationen?
Bitte kontaktieren Sie uns.

Kontakt aufnehmen